Literature DB >> 16930709

CpG-mediated changes in gene expression in murine spleen cells identified by microarray analysis.

Sven Klaschik1, Ihsan Gursel, Dennis M Klinman.   

Abstract

Unmethylated CpG motifs interact with Toll-like receptor 9 (TLR9), triggering an innate immune response characterized by the production of cytokines, chemokines and immunoglobulins. Microarray analysis of cDNA from murine spleen cells stimulated with CpG oligodeoxynucleotides (ODN) identified reproducible changes in gene expression over time. Eight genes are significantly up-regulated 2h post CpG ODN stimulation, most of which contribute to the induction of innate or adaptive immune responses. Network analysis indicates that TNF and NFKB1 are key regulators of gene expression at this early time point. At 4h, IL1B in addition to TNF and NFKB1 play dominant roles in the up-regulation of immune gene expression, whereas by 8h this function is mediated by TNF, IFNG, and MYC. Genes responsible for down-regulating CpG-induced responses were also identified, dampening what would otherwise be a continuous positive feedback loop. This work provides novel insights into the regulatory process embedded in the gene expression profile induced by CpG ODN, identifies novel genes associated with CpG-induced immune stimulation, and clarifies the breadth of the immune response elicited via TLR9.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930709     DOI: 10.1016/j.molimm.2006.07.283

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  18 in total

1.  Activation of type I interferon-dependent genes characterizes the "core response" induced by CpG DNA.

Authors:  Folkert Steinhagen; Corinna Meyer; Debra Tross; Mayda Gursel; Takahiro Maeda; Sven Klaschik; Dennis M Klinman
Journal:  J Leukoc Biol       Date:  2012-07-02       Impact factor: 4.962

2.  TLR7 and TLR9 ligands regulate antigen presentation by macrophages.

Authors:  Teja Celhar; Selma Pereira-Lopes; Susannah I Thornhill; Hui Yin Lee; Manprit K Dhillon; Michael Poidinger; John E Connolly; Lina H K Lim; Subhra K Biswas; Anna-Marie Fairhurst
Journal:  Int Immunol       Date:  2015-11-13       Impact factor: 4.823

3.  Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology.

Authors:  Henrieta Scholtzova; Richard J Kascsak; Kristyn A Bates; Allal Boutajangout; Daniel J Kerr; Harry C Meeker; Pankaj D Mehta; Daryl S Spinner; Thomas Wisniewski
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

4.  Inductive and suppressive networks regulate TLR9-dependent gene expression in vivo.

Authors:  Sven Klaschik; Debra Tross; Dennis M Klinman
Journal:  J Leukoc Biol       Date:  2009-01-29       Impact factor: 4.962

5.  A suppressive oligodeoxynucleotide expressing TTAGGG motifs modulates cellular energetics through the mTOR signaling pathway.

Authors:  Volkan Yazar; Gizem Kilic; Ozlem Bulut; Tugce Canavar Yildirim; Fuat C Yagci; Gamze Aykut; Dennis M Klinman; Mayda Gursel; Ihsan Gursel
Journal:  Int Immunol       Date:  2020-01-09       Impact factor: 4.823

6.  Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants.

Authors:  Dennis M Klinman; Sven Klaschik; Koji Tomaru; Hidekazu Shirota; Debra Tross; Hidekazu Ikeuchi
Journal:  Vaccine       Date:  2010-02-23       Impact factor: 3.641

7.  Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice.

Authors:  Sally M Amos; Hollie J Pegram; Jennifer A Westwood; Liza B John; Christel Devaud; Chris J Clarke; Nicholas P Restifo; Mark J Smyth; Phillip K Darcy; Michael H Kershaw
Journal:  Cancer Immunol Immunother       Date:  2011-02-16       Impact factor: 6.968

8.  Accelerated wound healing mediated by activation of Toll-like receptor 9.

Authors:  Takashi Sato; Masaki Yamamoto; Takeshi Shimosato; Dennis M Klinman
Journal:  Wound Repair Regen       Date:  2010-10-13       Impact factor: 3.617

9.  Short- and long-term changes in gene expression mediated by the activation of TLR9.

Authors:  Sven Klaschik; Debra Tross; Hidekazu Shirota; Dennis M Klinman
Journal:  Mol Immunol       Date:  2009-12-14       Impact factor: 4.407

10.  Global changes in gene expression and synergistic interactions induced by TLR9 and TLR3.

Authors:  Debra Tross; Lev Petrenko; Sven Klaschik; Qing Zhu; Dennis M Klinman
Journal:  Mol Immunol       Date:  2009-06-16       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.